{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T03:22:18Z","timestamp":1790565738166,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T00:00:00Z","timestamp":1739491200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.biopha.2025.117922","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T23:05:43Z","timestamp":1740092743000},"page":"117922","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Amlexanox ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting Th17 cells and the NF-\u03baB signal pathway"],"prefix":"10.1016","volume":"184","author":[{"given":"Juan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanhua","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.biopha.2025.117922_bib1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/1346-8138.15727","article-title":"Psoriasis: recent progress in molecular-targeted therapies","volume":"48","author":"Honma","year":"2021","journal-title":"J. Dermatol."},{"key":"10.1016\/j.biopha.2025.117922_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.743180","article-title":"The global, regional, and national burden of psoriasis: results and insights from the global burden of disease 2019 study","volume":"8","author":"Damiani","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2025.117922_bib3","doi-asserted-by":"crossref","first-page":"m1590","DOI":"10.1136\/bmj.m1590","article-title":"National, regional, and worldwide epidemiology of psoriasis: systematic analysis and modelling study","volume":"369","author":"Parisi","year":"2020","journal-title":"Bmj"},{"issue":"8","key":"10.1016\/j.biopha.2025.117922_bib4","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1001\/jamadermatol.2021.2007","article-title":"Psoriasis prevalence in adults in the United States","volume":"157","author":"Armstrong","year":"2021","journal-title":"JAMA Dermatol."},{"issue":"4","key":"10.1016\/j.biopha.2025.117922_bib5","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00403-024-02846-z","article-title":"Global burden and future trends in psoriasis epidemiology: insights from the global burden of disease study 2019 and predictions to 2030","volume":"316","author":"Wang","year":"2024","journal-title":"Arch. Dermatol. Res."},{"issue":"9997","key":"10.1016\/j.biopha.2025.117922_bib6","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.biopha.2025.117922_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11070347","article-title":"Drug delivery systems for vitamin D supplementation and therapy","volume":"11","author":"Glowka","year":"2019","journal-title":"Pharmaceutics"},{"issue":"19","key":"10.1016\/j.biopha.2025.117922_bib8","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"Jama"},{"issue":"4","key":"10.1016\/j.biopha.2025.117922_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/ijd.12790","article-title":"The role of vitamin D in psoriasis: a review","volume":"54","author":"Soleymani","year":"2015","journal-title":"Int J. Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.117922_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020530","article-title":"Role of the IL-23\/IL-17 axis in psoriasis and psoriatic arthritis: the clinical importance of its divergence in skin and joints","volume":"19","author":"Boutet","year":"2018","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2025.117922_bib11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/jid.2009.399","article-title":"Circulating Th17, Th22, and Th1 cells are increased in psoriasis","volume":"130","author":"Kagami","year":"2010","journal-title":"J. Invest Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.117922_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2016.03.048","article-title":"Topical application of a vitamin D3 analogue and corticosteroid to psoriasis plaques decreases skin infiltration of TH17 cells and their ex vivo expansion","volume":"138","author":"Fujiyama","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.biopha.2025.117922_bib13","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.3389\/fimmu.2018.01323","article-title":"The interleukin-23\/Interleukin-17 axis links adaptive and innate immunity in psoriasis","volume":"9","author":"Sch\u00f6n","year":"2018","journal-title":"Front Immunol."},{"key":"10.1016\/j.biopha.2025.117922_bib14","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejphar.2015.12.040","article-title":"Paeoniflorin inhibits imiquimod-induced psoriasis in mice by regulating Th17 cell response and cytokine secretion","volume":"772","author":"Zhao","year":"2016","journal-title":"Eur. J. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2025.117922_bib15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/1744666X.2020.1771182","article-title":"TNF-\u03b1 inhibitors biosimilars as first line systemic treatment for moderate-to-severe chronic plaque psoriasis","volume":"16","author":"Gisondi","year":"2020","journal-title":"Expert Rev. Clin. Immunol."},{"issue":"1","key":"10.1016\/j.biopha.2025.117922_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000234292","article-title":"Mechanism of action of an antiallergic agent, amlexanox (AA-673), in inhibiting histamine release from mast cells. Acceleration of cAMP generation and inhibition of phosphodiesterase","volume":"82","author":"Makino","year":"1987","journal-title":"Int Arch. Allergy Appl. Immunol."},{"issue":"4","key":"10.1016\/j.biopha.2025.117922_bib17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.2042-7158.1990.tb05399.x","article-title":"Inhibitory effect of HSR-6071, a new anti-allergic agent, on experimental asthma in rats and guinea-pigs","volume":"42","author":"Makino","year":"1990","journal-title":"J. Pharm. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2025.117922_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1159\/000233837","article-title":"Inhibition by amoxanox (AA-673) of the immunologically, leukotriene D4- or platelet-activating factor-stimulated bronchoconstriction in guinea pigs and rats","volume":"77","author":"Saijo","year":"1985","journal-title":"Int Arch. Allergy Appl. Immunol."},{"issue":"8","key":"10.1016\/j.biopha.2025.117922_bib19","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1248\/bpb1978.14.467","article-title":"Inhibitory effect of levocabastine on experimental allergic conjunctivitis in Guinea Pigs","volume":"14","author":"Kamei","year":"1991","journal-title":"J. Pharm. -Dyn."},{"issue":"9","key":"10.1016\/j.biopha.2025.117922_bib20","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2165\/00044011-200525090-00001","article-title":"Amlexanox for the treatment of recurrent aphthous ulcers","volume":"25","author":"Bell","year":"2005","journal-title":"Clin. Drug Invest."},{"issue":"3","key":"10.1016\/j.biopha.2025.117922_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nm.3082","article-title":"An inhibitor of the protein kinases TBK1 and IKK-\u025b improves obesity-related metabolic dysfunctions in mice","volume":"19","author":"Reilly","year":"2013","journal-title":"Nat. Med"},{"issue":"5","key":"10.1016\/j.biopha.2025.117922_bib22","first-page":"759","article-title":"Amlexanox: a novel therapeutic for atopic, metabolic, and inflammatory disease","volume":"93","author":"Dosanjh","year":"2020","journal-title":"Yale J. Biol. Med"},{"issue":"17","key":"10.1016\/j.biopha.2025.117922_bib23","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.155552","article-title":"The TBK1\/IKK\u03b5 inhibitor amlexanox improves dyslipidemia and prevents atherosclerosis","volume":"7","author":"Zhao","year":"2022","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.biopha.2025.117922_bib24","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12906-016-1325-4","article-title":"Epigallocatechin-3-gallate (EGCG) inhibits imiquimod-induced psoriasis-like inflammation of BALB\/c mice","volume":"16","author":"Zhang","year":"2016","journal-title":"BMC Complement Alter. Med"},{"key":"10.1016\/j.biopha.2025.117922_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115307","article-title":"Tranexamic acid improves psoriasis-like skin inflammation: evidence from in vivo and in vitro studies","volume":"166","author":"Hseu","year":"2023","journal-title":"Biomed. Pharm."},{"issue":"3 Pt B","key":"10.1016\/j.biopha.2025.117922_bib26","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jid.2021.06.019","article-title":"Mouse models of psoriasis: a comprehensive review","volume":"142","author":"Gangwar","year":"2022","journal-title":"J. Invest Dermatol."},{"issue":"3","key":"10.1016\/j.biopha.2025.117922_bib27","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jid.2016.10.024","article-title":"The snowballing literature on imiquimod-induced skin inflammation in mice: a critical appraisal","volume":"137","author":"Hawkes","year":"2017","journal-title":"J. Invest Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.117922_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaad.2021.07.040","article-title":"Efficacy and safety of apremilast in patients with mild-to-moderate plaque psoriasis: results of a phase 3, multicenter, randomized, double-blind, placebo-controlled trial","volume":"86","author":"Stein Gold","year":"2022","journal-title":"J. Am. Acad. Dermatol."},{"issue":"2","key":"10.1016\/j.biopha.2025.117922_bib29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2174\/1574886315666200128095958","article-title":"Treatment of psoriasis: a comprehensive review of entire therapies","volume":"15","author":"Bakshi","year":"2020","journal-title":"Curr. Drug Saf."},{"issue":"6","key":"10.1016\/j.biopha.2025.117922_bib30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cytogfr.2010.10.007","article-title":"Distinct roles of IL-22 in human psoriasis and inflammatory bowel disease","volume":"21","author":"Ouyang","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"issue":"8","key":"10.1016\/j.biopha.2025.117922_bib31","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/jdv.16273","article-title":"The role of the interleukin-23\/Th17 pathway in cardiometabolic comorbidity associated with psoriasis","volume":"34","author":"Egeberg","year":"2020","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.biopha.2025.117922_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106767","article-title":"Hispidulin alleviates imiquimod-induced psoriasis-like skin inflammation by inhibiting splenic Th1\/Th17 cell population and keratinocyte activation","volume":"87","author":"Kim","year":"2020","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2025.117922_bib33","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1038\/ncomms8652","article-title":"NF-\u03baB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis","volume":"6","author":"Yan","year":"2015","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biopha.2025.117922_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2019.01.014","article-title":"IL-17 and IL-22 promote keratinocyte stemness in the germinative compartment in psoriasis","volume":"139","author":"Ekman","year":"2019","journal-title":"J. Invest Dermatol."},{"issue":"6","key":"10.1016\/j.biopha.2025.117922_bib35","doi-asserted-by":"crossref","first-page":"924","DOI":"10.3390\/jpm12060924","article-title":"Metabolic profiling in rheumatoid arthritis, psoriatic arthritis, and psoriasis: elucidating pathogenesis, improving diagnosis, and monitoring disease activity","volume":"12","author":"Dorochow","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.biopha.2025.117922_bib36","doi-asserted-by":"crossref","first-page":"7692024","DOI":"10.1155\/2016\/7692024","article-title":"T helper cell subsets in clinical manifestations of psoriasis","volume":"2016","author":"Diani","year":"2016","journal-title":"J. Immunol. Res"},{"key":"10.1016\/j.biopha.2025.117922_bib37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.imlet.2020.11.005","article-title":"Increased peripheral helper T cells type 17 subset correlates with the severity of psoriasis vulgaris","volume":"229","author":"Liu","year":"2021","journal-title":"Immunol. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2025.117922_bib38","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jdermsci.2020.01.011","article-title":"Diet-induced obesity exacerbates imiquimod-mediated psoriasiform dermatitis in anti-PD-1 antibody-treated mice: implications for patients being treated with checkpoint inhibitors for cancer","volume":"97","author":"Yu","year":"2020","journal-title":"J. Dermatol. Sci."},{"issue":"9","key":"10.1016\/j.biopha.2025.117922_bib39","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.biopha.2025.117922_bib40","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1056\/NEJMra0707449","article-title":"Interleukin-17 and type 17 helper T cells","volume":"361","author":"Miossec","year":"2009","journal-title":"N. Engl. J. Med"},{"issue":"5","key":"10.1016\/j.biopha.2025.117922_bib41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s12026-020-09149-1","article-title":"The role of Th17 cells in psoriasis","volume":"68","author":"Li","year":"2020","journal-title":"Immunol. Res"},{"issue":"11","key":"10.1016\/j.biopha.2025.117922_bib42","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.jid.2024.06.1280","article-title":"The central roles of keratinocytes in coordinating skin immunity","volume":"144","author":"Simmons","year":"2024","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.biopha.2025.117922_bib43","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.clindermatol.2007.08.012","article-title":"Immunopathogenesis and role of T cells in psoriasis","volume":"25","author":"Ghoreschi","year":"2007","journal-title":"Clin. Dermatol."},{"issue":"7","key":"10.1016\/j.biopha.2025.117922_bib44","article-title":"Extracts from seseli mairei wolff attenuate imiquimod-induced psoriasis-like inflammation by inhibiting Th17 cells","volume":"9","author":"Wang","year":"2023","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.biopha.2025.117922_bib45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jdermsci.2012.11.002","article-title":"NF-\u03baB: An essential transcription factor in psoriasis","volume":"69","author":"Goldminz","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.biopha.2025.117922_bib46","article-title":"Allicin Ameliorates IMQ-induced psoriasis-like Skin Inflammation Via Disturbing the Interaction of Keratinocytes with IL-17A","author":"Zhang","year":"2022","journal-title":"Author Prepr."},{"issue":"4","key":"10.1016\/j.biopha.2025.117922_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00357","article-title":"A phosphodiesterase 4 (PDE4) inhibitor, amlexanox, reduces neuroinflammation and neuronal death after pilocarpine-induced seizure","volume":"21","author":"Yang","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.biopha.2025.117922_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2020.118766","article-title":"Amlexanox exerts anti-inflammatory actions by targeting phosphodiesterase 4B in lipopolysaccharide-activated macrophages","volume":"1867","author":"Han","year":"2020","journal-title":"Biochim Biophys. Acta Mol. Cell Res"},{"issue":"1","key":"10.1016\/j.biopha.2025.117922_bib49","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1038\/s41598-024-53235-5","article-title":"Amlexanox attenuates LPS-induced neuroinflammatory responses in microglial cells via inhibition of NF\u2013\u03baB and STAT3 signaling pathways","volume":"14","author":"Phan Van","year":"2024","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.biopha.2025.117922_bib50","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1021\/acsomega.0c05399","article-title":"Amlexanox enhances temozolomide-induced antitumor effects in human glioblastoma cells by inhibiting IKBKE and the Akt-mTOR signaling pathway","volume":"6","author":"Xiong","year":"2021","journal-title":"ACS Omega"},{"issue":"2","key":"10.1016\/j.biopha.2025.117922_bib51","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1079-2104(97)90010-X","article-title":"5% Amlexanox oral paste, a new treatment for recurrent minor aphthous ulcers: II: Pharmacokinetics and demonstration of clinical safety","volume":"83","author":"Khandwala","year":"1997","journal-title":"Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endodontol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225001167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T23:45:54Z","timestamp":1741045554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225001167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":51,"alternative-id":["S0753332225001167"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117922","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amlexanox ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting Th17 cells and the NF-\u03baB signal pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.117922","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"117922"}}